Q2 2026 Earnings Call February 10, 2026 6:00 PM ESTCompany ParticipantsMark DehringGordon NaylorKen Lim - Chief Financial ...

Commerce Advertising, has published its semi-annual industry report, "State of Commerce Advertising 1/2026". The results are based on a survey of publishers, advertisers, and networks and highlight ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

The FDA underwent significant changes during the first year of the second Trump administration, directly affecting business ...

By Kamal Choudhury Feb 9 (Reuters) - Privately held Iambic said on Monday it has entered a multi-year partnership worth more ...

A year of significant policy change at the FDA brought momentum and scrutiny into the new year. As 2026 gets underway, biopharma companies are responding to sweeping vaccine changes while concerns ...

FDA's new medical device quality management rules align U.S. standards with global requirements and give inspectors new ...

FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...

Step behind electric gates onto a private road in Solihull, where this newly built ultra-modern home pairs bold materials with calm, minimalist interiors. Inside, you’ll find polished concrete floors ...

Novartis today broke ground on a new, state-of-the-art global Biomedical Research center in San Diego, California, designed to provide world-class scientific infrastructure and drug-discovery ...

Wave is expecting feedback from US regulators on a path forward for WVE-006 as a potential alpha-1 antitrypsin deficiency therapy in mid-2026.